Syncom Formulations (India) Ltd.

₹15.07

- 0.25 (-1.63%)

04:01 pm - close price

BSE: SYNCOMF

NSE: SYNCOMF

Industry: Pharmaceuticals & Drugs

House: Private

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.

Ratios

Reported EPS

Bad: 2Current: 0.53Good: 5

❌

Adjusted EPS

Bad: 3Current: 0.53Good: 6

❌

Return On Capital Employed (ROCE)

Bad: 10Current: 18.77Good: 20

🟡

Current Ratio

Bad: 1Current: 4.41Good: 2

✅

Return On Equity (ROE)

Bad: 5Current: 15.69Good: 15

✅

Debt to Total Assets

Bad: 1Current: 1.10Good: 0.5

❌

Scroll vertically to see more ratios

Reported EPS

Bad: 2Current: 0.53Good: 5

❌

Adjusted EPS

Bad: 3Current: 0.53Good: 6

❌

Return On Capital Employed (ROCE)

Bad: 10Current: 18.77Good: 20

🟡

Current Ratio

Bad: 1Current: 4.41Good: 2

✅

Return On Equity (ROE)

Bad: 5Current: 15.69Good: 15

✅

Debt to Total Assets

Bad: 1Current: 1.10Good: 0.5

❌

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

Peer Comparison

Consolidated

company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.99	16.16	26.60	20.88	45.55	45.55	16.00	2.89	2.33	0.03	60.44	0.62	38.10	30.72	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.02	15.35	31.03	23.29	82.68	82.68	30.00	4.84	3.40	0.00	973.00	0.56	69.83	59.00	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	15.36	18.34	18.58	14.29	65.29	65.29	16.00	4.24	3.21	0.00	111.00	1.08	22.08	18.20	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	13.23	26.46	17.36	11.34	56.47	56.47	32.00	1.19	0.66	0.40	11.59	1.17	57.28	40.45	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	14.77	21.08	13.61	10.10	44.99	44.99	11.00	1.89	1.45	0.13	32.55	1.46	19.69	16.11	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	13.41	18.61	24.39	17.54	67.81	67.81	8.00	1.92	1.37	0.14	28.15	0.76	16.87	12.84	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	12.63	21.13	11.59	8.89	71.87	71.87	12.00	1.87	1.26	0.30	14.62	1.42	28.20	20.67	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	10.15	16.98	23.25	15.83	48.25	48.25	0	1.23	0.86	0.58	6.83	0.64	50.22	38.05	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	7.54	11.15	8.69	5.48	60.02	60.02	0	1.85	1.13	0.24	12.08	1.38	19.32	13.12	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	14.77	19.93	13.72	11.48	181.14	181.14	45.00	2.73	1.99	0.09	21.76	1.29	26.94	22.67	6.85	26.10	0.64

Scroll horizontally to see more columns

Quarterly Results

In Rs. Cr.	2023-06	2023-09	2023-12	2024-03	2024-06
Net Sales	59.84	63.84	65.14	74.57	87.25
Expenditure+	53.38	57.43	57.78	65.15	76.80
Other Income+	1.88	4.00	4.55	3.10	1.34
Operating Profit	6.46	6.41	7.36	9.43	10.45
Interest	1.12	1.08	1.08	1.19	0.39
Depreciation and Amortization	1.10	0.88	1.45	1.30	1.30
Profit Before Tax	6.11	8.45	9.36	10.03	10.10
Tax+	1.72	1.94	2.36	2.63	2.47
Net Profit	4.40	6.51	7.00	7.40	7.63

Profit & Loss

In Rs. Cr.	201703	202203	202303	202403	202503
Sales	1848224245.00	21966.32	22425.42	26338.71	46501.26
Operational Expenses+	1682696056.00	19962.79	20435.42	23373.97	41088.09
Operating Profit	165528189.00	2003.53	1990.00	2964.74	5413.17
Other Income	27908381.00	1199.25	1459.99	1352.59	1743.40
OPM %	8.96	9.12	8.87	11.26	11.64
Depreciation and Amortisation	31228155.00	394.84	453.93	472.23	519.39
Interest	3344150.00	192.76	340.13	447.41	86.49
Profit Before Tax	158774235.00	2617.59	2657.26	3395.30	6551.27
Tax	53433225.00	657.06	653.60	860.70	1626.73
Net Profit	105341010.00	1979.04	2007.07	2531.42	4943.46

Cash Flow Statement

In Rs. Cr.	201703	202103	202203	202303	202403	202503
Cash from Operating Activity+	1384.10	-	1632.90	1052.93	-595.83	2343.61
Cash from Investing Activity	-1768.42	-	-2707.33	-4495.27	8301.96	-1820.42
Cash from Financing Activity	466.86	-	829.45	3500.14	-1455.76	-6790.33
Net Cash Flow	82.54	-	-244.98	57.80	6250.37	-6267.14
Opening Cash & Cash Equivalents	569.41	-	275.15	30.17	87.97	6338.34
Closing Cash & Cash Equivalents	651.95	-	30.17	87.97	6338.34	71.20

Shareholder Pattern

In %	SEP'25	JUN'25	MAR'25	DEC'24	SEP'24	JUN'24	MAR'24	DEC'23	SEP'23	JUN'23
Promoters+	50.57	50.57	50.57	50.57	50.57	50.57	50.57	50.57	50.57	50.57
Public+	49.43	49.43	49.43	49.43	49.43	49.43	49.43	49.43	49.43	49.43
Custodians	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Number of Shareholders	457364	471066	484529	489520	469242	376530	325761	289982	224252	224925

Profit & Loss

In Rs. Cr.	201703	202203	202303	202403	202503
Sales	1848224245.00	21966.32	22425.42	26338.71	46501.26
Operational Expenses+	1682696056.00	19962.79	20435.42	23373.97	41088.09
Operating Profit	165528189.00	2003.53	1990.00	2964.74	5413.17
Other Income	27908381.00	1199.25	1459.99	1352.59	1743.40
OPM %	8.96	9.12	8.87	11.26	11.64
Depreciation and Amortisation	31228155.00	394.84	453.93	472.23	519.39
Interest	3344150.00	192.76	340.13	447.41	86.49
Profit Before Tax	158774235.00	2617.59	2657.26	3395.30	6551.27
Tax	53433225.00	657.06	653.60	860.70	1626.73
Net Profit	105341010.00	1979.04	2007.07	2531.42	4943.46

Quarterly Results

In Rs. Cr.	2023-06	2023-09	2023-12	2024-03	2024-06
Net Sales	59.84	63.84	65.14	74.57	87.25
Expenditure+	53.38	57.43	57.78	65.15	76.80
Other Income+	1.88	4.00	4.55	3.10	1.34
Operating Profit	6.46	6.41	7.36	9.43	10.45
Interest	1.12	1.08	1.08	1.19	0.39
Depreciation and Amortization	1.10	0.88	1.45	1.30	1.30
Profit Before Tax	6.11	8.45	9.36	10.03	10.10
Tax+	1.72	1.94	2.36	2.63	2.47
Net Profit	4.40	6.51	7.00	7.40	7.63

Cash Flow Statement

In Rs. Cr.	201703	202103	202203	202303	202403	202503
Cash from Operating Activity+	1384.10	-	1632.90	1052.93	-595.83	2343.61
Cash from Investing Activity	-1768.42	-	-2707.33	-4495.27	8301.96	-1820.42
Cash from Financing Activity	466.86	-	829.45	3500.14	-1455.76	-6790.33
Net Cash Flow	82.54	-	-244.98	57.80	6250.37	-6267.14
Opening Cash & Cash Equivalents	569.41	-	275.15	30.17	87.97	6338.34
Closing Cash & Cash Equivalents	651.95	-	30.17	87.97	6338.34	71.20

Shareholder Pattern

In %	SEP'25	JUN'25	MAR'25	DEC'24	SEP'24	JUN'24	MAR'24	DEC'23	SEP'23	JUN'23
Promoters+	50.57	50.57	50.57	50.57	50.57	50.57	50.57	50.57	50.57	50.57
Public+	49.43	49.43	49.43	49.43	49.43	49.43	49.43	49.43	49.43	49.43
Custodians	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Number of Shareholders	457364	471066	484529	489520	469242	376530	325761	289982	224252	224925

Peer Comparison

Consolidated

company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.99	16.16	26.60	20.88	45.55	45.55	16.00	2.89	2.33	0.03	60.44	0.62	38.10	30.72	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.02	15.35	31.03	23.29	82.68	82.68	30.00	4.84	3.40	0.00	973.00	0.56	69.83	59.00	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	15.36	18.34	18.58	14.29	65.29	65.29	16.00	4.24	3.21	0.00	111.00	1.08	22.08	18.20	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	13.23	26.46	17.36	11.34	56.47	56.47	32.00	1.19	0.66	0.40	11.59	1.17	57.28	40.45	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	14.77	21.08	13.61	10.10	44.99	44.99	11.00	1.89	1.45	0.13	32.55	1.46	19.69	16.11	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	13.41	18.61	24.39	17.54	67.81	67.81	8.00	1.92	1.37	0.14	28.15	0.76	16.87	12.84	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	12.63	21.13	11.59	8.89	71.87	71.87	12.00	1.87	1.26	0.30	14.62	1.42	28.20	20.67	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	10.15	16.98	23.25	15.83	48.25	48.25	0	1.23	0.86	0.58	6.83	0.64	50.22	38.05	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	7.54	11.15	8.69	5.48	60.02	60.02	0	1.85	1.13	0.24	12.08	1.38	19.32	13.12	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	14.77	19.93	13.72	11.48	181.14	181.14	45.00	2.73	1.99	0.09	21.76	1.29	26.94	22.67	6.85	26.10	0.64

Scroll horizontally to see more columns

Ratios

Reported EPS

Bad: 2Current: 0.53Good: 5

❌

Adjusted EPS

Bad: 3Current: 0.53Good: 6

❌

Return On Capital Employed (ROCE)

Bad: 10Current: 18.77Good: 20

🟡

Current Ratio

Bad: 1Current: 4.41Good: 2

✅

Return On Equity (ROE)

Bad: 5Current: 15.69Good: 15

✅

Debt to Total Assets

Bad: 1Current: 1.10Good: 0.5

❌

Scroll vertically to see more ratios

Reported EPS

Bad: 2Current: 0.53Good: 5

❌

Adjusted EPS

Bad: 3Current: 0.53Good: 6

❌

Return On Capital Employed (ROCE)

Bad: 10Current: 18.77Good: 20

🟡

Current Ratio

Bad: 1Current: 4.41Good: 2

✅

Return On Equity (ROE)

Bad: 5Current: 15.69Good: 15

✅

Debt to Total Assets

Bad: 1Current: 1.10Good: 0.5

❌

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.

Syncom Formulations (India) Ltd.

₹15.07

- 0.25 (-1.63%)

04:01 pm - close price

BSE: SYNCOMF

NSE: SYNCOMF

Industry: Pharmaceuticals & Drugs

House: Private

Overview